<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_5-6_207-19</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.207</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Scientific Papers</subject></subj-group>
</article-categories>
<title-group>
<article-title>Analysis of Mortality from Peripheral Artery Disease from 2011 to 2020 by Region in the Republic of Croatia</article-title>
<trans-title-group xml:lang="hr">
<trans-title>Analiza mortaliteta periferne arterijske bolesti od 2011. do 2020. godine po regijama u Republici Hrvatskoj</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3245-001X</contrib-id><name><surname>Biloglav</surname><given-names>Zrinka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7173-8286</contrib-id><name><surname>Medakovi&#x0107;</surname><given-names>Petar</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4323-4961</contrib-id><name><surname>Vidovi&#x0107;</surname><given-names>Dominic</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5098-1594</contrib-id><name><surname>Kova&#x010D;</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-1053-7562</contrib-id><name><surname>Bara&#x0107;</surname><given-names>Dea</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1842-930X</contrib-id><name><surname>&#x0160;krlec</surname><given-names>Ivana</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9249-9325</contrib-id><name><surname>Padjen</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6304-5829</contrib-id><name><surname>Turudi&#x0107;</surname><given-names>Matea</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2209-7635</contrib-id><name><surname>Andri&#x0107;</surname><given-names>Domagoj</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0041-4054</contrib-id><name><surname>Jakobovi&#x0107;</surname><given-names>Antun Tonko</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1134-4856</contrib-id><name><surname>Glava&#x0161;</surname><given-names>Blanka</given-names></name><ext-link ext-link-type="uri" xlink:href="https://orcid.org/">https://orcid.org/</ext-link><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3643-1713</contrib-id><name><surname>Relkovi&#x0107;</surname><given-names>Filip</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8212-9040</contrib-id><name><surname>Jupek</surname><given-names>Nikolina</given-names></name><xref ref-type="aff" rid="aff10"><sup>10</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2183-3506</contrib-id><name><surname>Rado&#x0161;</surname><given-names>Stipe</given-names></name><xref ref-type="aff" rid="aff11"><sup>11</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8825-2592</contrib-id><name><surname>&#x0106;uri&#x0107;</surname><given-names>Josip</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6613-9492</contrib-id><name><surname>Ti&#x0107;inovi&#x0107;</surname><given-names>Nino</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6984-3427</contrib-id><name><surname>Ru&#x017E;i&#x0107;</surname><given-names>Tatjana</given-names></name><xref ref-type="aff" rid="aff12"><sup>12</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4514-1400</contrib-id><name><surname>Kukuljan</surname><given-names>Melita</given-names></name><xref ref-type="aff" rid="aff13"><sup>13</sup></xref><xref ref-type="aff" rid="aff14"><sup>14</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3521-1564</contrib-id><name><surname>Kuhelj</surname><given-names>Dimitrij</given-names></name><xref ref-type="aff" rid="aff15"><sup>15</sup></xref><xref ref-type="aff" rid="aff16"><sup>16</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8477-8594</contrib-id><name><surname>Kova&#x010D;evi&#x0107;</surname><given-names>Miljenko</given-names></name><xref ref-type="aff" rid="aff12"><sup>12</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7419-224X</contrib-id><name><surname>Kova&#x010D;i&#x0107;</surname><given-names>Slavica</given-names></name><xref ref-type="aff" rid="aff12"><sup>12</sup></xref><xref ref-type="aff" rid="aff14"><sup>14</sup></xref></contrib>
<aff id="aff1"><label>1</label>&#x0160;kola narodnog zdravlja &#x201E;Andrija &#x0160;tampar&#x201C;, <addr-line>Zagreb</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff2"><label>2</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff3"><label>3</label><institution>Poliklinika CROATIA</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff4"><label>4</label><institution>Nastavni zavod za hitnu medicinu Zagreba&#x010D;ke &#x017E;upanije</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff5"><label>5</label><institution>Zavod za hitnu medicinu Dubrova&#x010D;ko-neretvanske &#x017E;upanije</institution>, <addr-line>Dubrovnik</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff6"><label>6</label>Fakultet za dentalnu medicinu i zdravstvo, Osijek, Sveu&#x010D;ili&#x0161;te &#x201E;Josip Juraj Strossmayer&#x201C;, <addr-line>Osijek</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff7"><label>7</label><institution>Klini&#x010D;ki bolni&#x010D;ki centar Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff8"><label>8</label><institution>Specijalna bolnica za medicinsku rehabilitaciju Krapinske Toplice, Krapinske Toplice</institution>, <country country="hr">Hrvatska</country></aff>
<aff id="aff9"><label>9</label>Ordination dr. Ostojic Evica, Be&#x010D;, Austrija</aff>
<aff id="aff10"><label>10</label><institution>Op&#x0107;a bolnica Dubrovnik</institution>, <addr-line>Dubrovnik</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff11"><label>11</label><institution>Klini&#x010D;ka bolnica Dubrava</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff12"><label>12</label><institution>Klini&#x010D;ki bolni&#x010D;ki centar Rijeka</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff13"><label>13</label><institution>Fakultet zdravstvenih studija Sveu&#x010D;ili&#x0161;ta u Rijeci</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff14"><label>14</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Rijeci</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Hrvatska</country></aff>
<aff id="aff15"><label>15</label>Univerzitetni klini&#x010D;ni center Ljubljana, Ljubljana, Slovenija</aff>
<aff id="aff16"><label>16</label>Medicinska Fakulteta Univerza v Ljubljani, Ljubljana, Slovenija</aff>
<aff id="aff17"><label>1</label><institution>School of Public Health &#x201E;Andrija &#x0160;tampar&#x201C;</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff18"><label>2</label><institution>University of Zagreb</institution>, <institution content-type="dept">School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff19"><label>3</label><institution>Polyclinic CROATIA</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff20"><label>4</label><institution>Teaching Institute for Emergency Medicine of the Zagreb County</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff21"><label>5</label><institution>Department of Emergency Medicine of the Dubrovnik-Neretva County</institution>, <addr-line>Dubrovnik</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff22"><label>6</label><institution content-type="dept">Faculty of Dental Medicine and Health</institution>, <institution>Josip Juraj Strossmayer University of Osijek</institution>, <addr-line>Osijek</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff23"><label>7</label><institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff24"><label>8</label><institution>Special Hospital for Medical Rehabilitation Krapinske Toplice, Krapinske Toplice</institution>, <country country="hr">Croatia</country></aff>
<aff id="aff25"><label>9</label><institution>Ordination of Dr. Ostojic Evica</institution>, <addr-line>Vienna</addr-line>, <country country="at">Austria</country></aff>
<aff id="aff26"><label>10</label><institution>Dubrovnik General Hospital</institution>, <addr-line>Dubrovnik</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff27"><label>11</label><institution>Dubrava Clinical Hospital, Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff28"><label>12</label><institution>University Hospital Centre Rijeka</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff29"><label>13</label><institution content-type="dept">Faculty of Health Studies</institution>, <institution>University of Rijeka</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff30"><label>14</label><institution content-type="dept">Faculty of Medicine</institution>, <institution>University of Rijeka</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff31"><label>15</label><institution>University Clinical Center Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country country="si">Slovenia</country></aff>
<aff id="aff32"><label>16</label><institution content-type="dept">Faculty of Medicine</institution>, <institution>University of Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country country="si">Slovenia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Petar Medakovi&#x0107;, Poliklinika CROATIA, Ulica Grada Vukovara 62, HR-10000 Zagreb, Croatia. / Phone: +385-72-000-999 / E-mail: <email xlink:href="eranio@gmx.at">eranio@gmx.at</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>04</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>04</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>5-6</issue>
<fpage>207</fpage>
<lpage>219</lpage>
<history>
<date date-type="received"><day>14</day><month>11</month><year>2023</year></date>
<date date-type="rev-recd"><day>03</day><month>02</month><year>2024</year></date>
<date date-type="accepted"><day>16</day><month>03</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<abstract>
<title>SUMMARY</title>
<p>Peripheral artery disease (PAD) is, along with ischemic heart disease and stroke, among the most significant diagnostic subgroups of cardiovascular diseases and one of the leading public health issues. Approximately 17 million people are affected by this disease in the European Union. Its real incidence and prevalence are several times higher than the estimates for this disease, and it is insufficiently diagnosed. The Republic of Croatia has a high burden and mortality from cardiovascular diseases. The goal of this analysis was to calculate and compare the age-standardized mortality rates for PAD based on sex and on 2<sup>nd</sup> level statistical regions in Croatia in the period from 2011 to 2020. Hospital information systems were searched for diagnoses that are applied for coding death from PAD in clinical practice and for coding interventional and diagnostic procedures, which were also supplemented by diagnoses from other studies. Based on data from the Croatian Institute of Public Health Mortality Database from 2011 to 2020, we calculated proportional mortality, percentage change for 2020 in comparison with 2011, and age-specific rates per 100 000 inhabitants. Statistical analysis used descriptive and analytic statistical methods. Among the 16 799 people who died, 10 352 were women and 6447 were men. Diagnosis I70.9, Generalized and non-specific atherosclerosis, was the most common at 43.2%. The highest age-standardize mortality rates in men and women were found in Northern Croatia, and the lowest in Adriatic Croatia. There were significant differences between regions in age-standardized mortality rates in both sexes. This study also showed an increase in the trend since 2018. In order to reduce mortality from PAD, efforts should be invested in prevention and early diagnostics and implementing systematic data collection on clinical outcomes for patient treatment.</p>
</abstract>
<trans-abstract xml:lang="hr">
<title>SA&#x017D;ETAK</title>
<p>Periferna arterijska bolest (PAB), uz ishemijsku bolest srca i mo&#x017E;dani udar, me&#x0111;u najzna&#x010D;ajnijim je dijagnosti&#x010D;kim podskupinama kardiovaskularnih bolesti i jedan od vode&#x0107;ih javnozdravstvenih problema. U Europskoj je uniji tom bole&#x0161;&#x0107;u zahva&#x0107;eno oko 17 milijuna ljudi. Stvarna incidencija i prevalencija vi&#x0161;estruko nadma&#x0161;uju procjene i bolest je nedostatno dijagnosticirana. Republika Hrvatska ima visoko optere&#x0107;enje i mortalitet od kardiovaskularnih bolesti. Svrha je ovoga rada izra&#x010D;unati i usporediti dobno standardizirane stope moraliteta od PAB-a prema statisti&#x010D;kim regijama 2. razine i spolu od 2011. do 2020. godine. Iz bolni&#x010D;kih informacijskih sustava odabrane su dijagnoze koje se u klini&#x010D;koj praksi primjenjuju za kodiranje smrti od PAB-a te za kodiranje interventnih i dijagnosti&#x010D;kih postupaka, a dopunjene su dijagnozama iz drugih istra&#x017E;ivanja. Na temelju podataka iz Baze umrlih Hrvatskog zavoda za javno zdravstvo od 2011. do 2020. godine izra&#x010D;unati su proporcionalni mortalitet, postotna promjena za 2020. godinu u odnosu prema 2011. godini i dobno specifi&#x010D;ne stope na 100 000 stanovnika. U statisti&#x010D;koj analizi primjenjivane su deskriptivne i analiti&#x010D;ke statisti&#x010D;ke metode. Me&#x0111;u 16 799 umrlih bile su 10 352 &#x017E;ene i 6447 mu&#x0161;karca. Dijagnoza I70.9 Generalizirana i nespecificirana ateroskleroza imala je najve&#x0107;i udio &#x2013; 43,2%. Najvi&#x0161;e dobno standardizirane stope mortaliteta u mu&#x0161;karaca i &#x017E;ena imala je Sjeverna Hrvatska, a najmanje Jadranska Hrvatska. Me&#x0111;u regijama postoje zna&#x010D;ajne razlike dobno standardiziranih stopa mortaliteta u obaju spolova. Ovo je istra&#x017E;ivanje tako&#x0111;er pokazalo porast trenda od 2018. godine. Kako bi se smanjio mortalitet od PAB-a, potrebno je ulo&#x017E;iti napore u prevenciju i ranu dijagnostiku te sustavno prikupljati podatke o klini&#x010D;kim ishodima lije&#x010D;enja bolesnika.</p>
</trans-abstract>
<kwd-group kwd-group-type="translator" xml:lang="hr"><title>KLJU&#x010C;NE RIJE&#x010C;I: </title><kwd>periferna arterijska bolest</kwd><kwd>mortalitet</kwd><kwd>dobno standardizirane stope</kwd><kwd>Republika Hrvatska</kwd></kwd-group>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>peripheral artery disease</kwd><kwd>mortality</kwd><kwd>age-standardized rates</kwd><kwd>Republic of Croatia</kwd></kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>The term peripheral artery disease (PAD) denotes the disease of blood vessels outside the heart and the brain. It is most commonly caused by atherosclerosis, and much less frequently by aneurysm, inflammation, or the joint effect of these pathophysiological processes. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) In clinical practice, the term PAD is used to describe chronic atherosclerotic obstructive diseases of the lower extremities.</p>
<p>Peripheral artery disease is, along with ischemic heart disease (IHD) and stroke, among the most significant diagnostic subgroups of cardiovascular diseases (CVDs). It represents one of the leading public health issues, and it is estimated that approximately 17 million people, i.e. 3.4% of the population, are affected by this disease in the European Union. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) The burden of this disease is increasing, and its global prevalence has increased by 23% between 2000 and 2010. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</p>
<p>Based on epidemiological research and experience from clinical practice, PAD is an insufficiently diagnosed disease in comparison with IHD, and its real incidence and prevalence are several times higher than current estimates. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r4"><italic>4</italic></xref>) A large number of patients with IHD also has clinically non-manifesting PAD, which negatively influences treatment outcomes. Therefore, the importance and necessity of screening such patients during clinical examination have been emphasized. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r6"><italic>6</italic></xref>)</p>
<p>Risk factors are identical to the traditional risk factors for other CVDs, the most important being smoking, diabetes, hypertension, and hypercholesterolemia. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) The Republic of Croatia is an EU country with a high burden of cardiovascular morbidity and mortality. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) No systematic studies that would explain the extremely high values of epidemiological indicators have been conducted, but it is clear that these values can be ascribed to a lack of prevention and insufficient effectiveness of healthcare intervetions. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>) It is also difficult to estimate the true effects of medical interventions, since there is a lack of data collection at the secondary and tertiary healthcare levels and a lack of data comparing treatment outcomes due to the lacking interconnectedness of hospital information systems in medical institutions. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>) Of the epidemiological indicators that can be used to show the dynamics of the disease in the population at the individual level, only data on cause of death are systematically available.</p>
<p>The goal of this study was to compare the age-standardized mortality rates due to PAD according to 2<sup>nd</sup> level statistical regions (NUTS-2) and according to sex in the Republic of Croatia from 2011 to 2020.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>SOURCES AND DATA COLLECTION</title>
<p>In clinical practice, peripheral artery disease encompasses a whole spectrum of diagnosis, and large differences have been observed both within and among different countries. Due to the possibility of misclassification bias among hospitals in the context of choice of diagnosis and in order to achieve higher clinical reliability, two specialist physicians, namely a interventional radiologist from the Dubrava Clinical Hospital and an internist from the Zagreb Clinical Hospital Center, were engaged to examine hospital information systems and choose the diagnoses that are applied in coding PAD and interventional and diagnostic procedures in these patients. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>, <xref ref-type="bibr" rid="r11"><italic>11</italic></xref>) These diagnoses were supplemented by diagnoses used in other studies. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>, <xref ref-type="bibr" rid="r12"><italic>12</italic></xref>-<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>)</p>
<p>Subsequently, the Mortality Database of the Croatian Institute of Public Health was used to collect data for the period from 2011 to 2020, stratified by five-year age groups for patients between the ages of 0 and 85+, by sex, and by county, as shown in <xref ref-type="table" rid="t1"><bold>Table 1</bold></xref>.</p>
<table-wrap id="t1" position="float">
<label>TABLE 1</label><caption><title>Diagnoses used in peripheral artery disease coding and interventional and diagnostic procedures.</title>
</caption>
<table frame="hsides" rules="groups">
<col width="100%"/>
<thead>
<tr>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E10.5 Insulin-dependent diabetes with peripheral circulatory complications</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E10.7 Insulin-dependent diabetes with multiple complications</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E11.5 Non-insulin-dependent diabetes mellitus with peripheral circulatory complications</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E11.7 Non-insulin-dependent diabetes mellitus, with multiple complications</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E13.7 Other specified diabetes, with multiple complications</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E14.5 Diabetes mellitus, unspecified, with peripheral circulatory complications</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">E14.7 Diabetes mellitus, unspecified, with multiple complications</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I70.0 Atherosclerosis of the aorta</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I70.1 Atherosclerosis of renal artery</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I70.2 Atherosclerosis of arteries of limbs</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I70.8 Atherosclerosis of other arteries</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I70.9 Generalized and unspecified atherosclerosis</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I73.9 Disease of peripheral blood vessels, unspecified</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I74.2 Embolism and thrombosis of the arteries of the hand</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I74.3 Embolism and thrombosis of leg arteries</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I74.4 Embolism and thrombosis of arteries of limbs, unspecified</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I74.5 Embolism and thrombosis of iliac artery</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I74.8 Embolism and thrombosis of other arteries</td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">I74.9 Embolism and thrombosis of unspecified arteries</td>
</tr>
</tbody></table></table-wrap>
<p>The population census by county was taken from the webpages of the Croatian Bureau of Statistics based on estimates made at the middle of each of the examined years. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>)</p>
<p>Based on the National Classification of Statistical Regions from 2021, the Republic of Croatia is divided into four NUTS-2 regions: (1) the City of Zagreb, (ii) Northern Croatia, (iii) Pannonian Croatia, and (iv) Adriatic Croatia (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>). (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>)</p>
<fig id="f1" position="float" fig-type="figure"><label>FIGURE 1</label><caption><p>Map of regions and associated counties in Croatia.</p></caption><graphic xlink:href="CC202419_5-6_207-19-f1"></graphic></fig>
</sec>
<sec>
<title>CALCULATING GENERAL, AGE-SPECIFIC, AND AGE-STANDARDIZED RATES</title>
<p>For each of the diagnoses listed above, we calculated proportional mortality as the ratio of deaths from individual diagnoses in the total number of PAD deaths from 2011 to 2020. The percentage change was calculated for 2020 in comparison with 2011.</p>
<p>General mortality rates for the total population for 2020 are shown as the total number of deaths from the examined diagnoses per 100 000 inhabitants. (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>) Age-specific rates were applied to the calculation of age-standardized rates based on the revised European Standard Population (RESP) from 2013 by multiplying age-specific rates (from age 0 to 85+) with weighted standard population averages. RESP 2013 is based on population projections for EU-27 member states and members of the European Free Trade Association for the period from 2011 to 2030 and is divided into five-year age groups, with the exception of the first group with the age category of 0, and with the oldest age group being 95+. (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>, <xref ref-type="bibr" rid="r19"><italic>19</italic></xref>)</p>
</sec>
<sec>
<title>STATISTICAL ANALYSIS</title>
<p>Data analysis and mapping were performed in the Microsoft Excel 365 computer program for spreadsheeting and data analysis (Microsoft Corporation, Redmond, Washington, USA). Statistical analysis employed descriptive and analytic statistical methods. The T-test and ANOVA were used for comparing continuous variables, and statistical significance was set at p&lt;0.05. Statistical analyses were performed using the SPSS Statistics 26 program (IBM, Amonk, New York, USA) as well as JASP 0.17.2. (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>)</p>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>ABSOLUTE MORTALITY NUMBERS AND PROPORTIONAL MORTALITY</title>
<p>A total of 16 799 persons died from PAD from 2011 to 2002, of whom 10 352 were women and 6447 were men. Among the total number of deaths, the cause with the highest ratio was I70.9, Generalized and non-specific atherosclerosis (43.2%), followed by I70.2, Atherosclerosis of arteries in the limbs (14.3%), and E14.7, Diabetes, non-specific, with multiple complications (11.5%), with other ratios shown in <xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>.</p>
<fig id="f2" position="float" fig-type="figure"><label>FIGURE 2</label><caption><p>Proportional mortality according to the International Classification of disease diagnoses, both sexes, 2011-2020. M = males; F = females.</p></caption><graphic xlink:href="CC202419_5-6_207-19-f2"></graphic></fig>
<p>The percentage change from 2011 to 2020 for men by region was as follows: the City of Zagreb 60.71%, Adriatic Croatia 21.43%, Pannonian Croatia 20.45%, and Northern Croatia 10.94%. For women, this percentage change was: the City of Zagreb 38.13%, Adriatic Croatia 13.49%, Pannonian Croatia 9.17%, and Northern Croatia 8.61% (<xref ref-type="fig" rid="f3"><bold>Figure 3</bold></xref>).</p>
<fig id="f3" position="float" fig-type="figure"><label>FIGURE 3</label><caption><p>Age-standardized rates of peripheral artery disease / 100 000 population (males and females).</p></caption><graphic xlink:href="CC202419_5-6_207-19-f3"></graphic></fig>
<p>The ratio between the highest and lowest rates for 2020 was lower in men, i.e. 1.4 (the City of Zagreb vs. Adriatic Croatia), in comparison with women, in whom it was 1.7 (the City of Zagreb vs. Adriatic Croatia).</p>
<p>Northern Croatia had the highest age-standardized mortality rates per 100 000 inhabitants both in men and in women &#x2013; 55.62 and 53.10 (<xref ref-type="table" rid="t2"><bold>Table 2</bold></xref>). It was followed by the City of Zagreb, Pannonian Croatia, and Adriatic Croatia. Mean values for mortality rates in men were higher for all NUTS-2 regions except for the City of Zagreb, where higher rates were observed in women.</p>
<table-wrap id="t2" position="float">
<label>TABLE 2</label><caption><title>Age-standardized mortality rates (per 100.000) from peripheral artery disease by region and sex, 2011-2020.</title>
</caption>
<table frame="hsides" rules="groups">
<col width="13.5%"/>
<col width="11.69%"/>
<col width="19.62%"/>
<col width="16.25%"/>
<col width="16.12%"/>
<col width="22.82%"/>
<thead>
<tr>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>City of Zagreb</bold></th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Adriatic Croatia</bold></th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Pannonian Croatia</bold></th>
<th valign="top" align="center" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Northern Croatia</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3" valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">Men</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">51.78</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">40.53</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">48.52</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">55.62</td>
</tr>
<tr>
<td valign="top" colspan="1" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">SD</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">11.44</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">6.51</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">8.47</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">11.11</td>
</tr>
<tr>
<td valign="top" colspan="1" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">Range</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">36.51 &#x2013; 74.07</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">31.86 &#x2013; 50.14</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">36.13 &#x2013; 61.13</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">39.80 &#x2013; 73.00</td>
</tr>
<tr>
<td rowspan="3" valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">Women</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">51.94</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">33.05</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">39.17</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">53.10</td>
</tr>
<tr>
<td valign="top" colspan="1" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">SD</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">10.07</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">5.87</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">7.20</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">10.62</td>
</tr>
<tr>
<td valign="top" colspan="1" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">Range</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">36.00 &#x2013; 71.00</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">25.66 &#x2013; 40.37</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">28.65 &#x2013; 50.81</td>
<td valign="top" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">35.01 &#x2013; 69.65</td>
</tr>
<tr>
<td colspan="6" valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt" scope="col">SD = standard deviation</td>
</tr>
</tbody></table></table-wrap>
<p>We observed statistically significant differences in mortality rates in men and women. In Pannonian Croatia, men had significantly higher mortality rates in comparison with women (p=0.02), which was also the case in Adriatic Croatia (p=0.01), whereas the rates were similar in the City of Zagreb (p=0.97) and in Northern Croatia (p=0.61).</p>
<p>The differences in average age-standardized mortality rates from PAD for men were statistically significant (p&lt;0.001). Adriatic Croatia had significantly lower rates than Northern Croatia (p&lt;0.001), whereas there were no significant differences between the other NUTS-2 regions. In women, the inter-regional differences were also statistically significant (p&lt;0.001). The City of Zagreb had significantly higher rates than Adriatic Croatia (p&lt;0.001) and Pannonian Croatia (p=0.01), and similar rates as Northern Croatia (p=0.99). The differences were also statistically significant when comparing Northern Croatia and Adriatic Croatia (p&lt;0.001); Northern Croatia and Pannonian Croatia (p&lt;0.001); and Adriatic Croatia and Pannonian Croatia (p=0.04) (<xref ref-type="fig" rid="f4"><bold>Figure 4</bold></xref>).</p>
<fig id="f4" position="float" fig-type="figure"><label>FIGURE 4</label><caption><p>Average age-standardized mortality rates from peripheral artery disease 2011-2020 (men and women). ASMR = age-standardized mortality rates; M = males; F = females</p></caption><graphic xlink:href="CC202419_5-6_207-19-f4"></graphic></fig>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>This study was the first to analyze age-standardized mortality rates due to PAD at the national and regional levels, as well as their trends from 2011 to 2020. Since 2018, mortality has increased in all NUTS-2 regions in Croatia, with significant regional differences in average mortality rates by sex.</p>
<p>Among the 16 799 deaths due to PAD, the highest proportional mortality was for the diagnoses I70.9 (43.2%) and I70.2 (14.3%), followed by diagnoses associated with diabetes, which can be explained by the high atherogenic potential of this disease (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>). The effects of diabetes on morbidity and mortality in the population are undoubtably underestimated both in official statistics and in clinical practice. (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref>, <xref ref-type="bibr" rid="r22"><italic>22</italic></xref>) Of all NUTS-2 regions, the greatest percentage change in mortality in 2020 in comparison with 2011 for both men and women was found in the City of Zagreb; 60.71% and 38.13%, respectively. For men, the City of Zagreb was followed by Adriatic and Pannonian Croatia with regard to percentage change, with similar percentages, and ultimately also by Northern Croatia. The ranking was the same for women, but the percentage increases were lower. The increase in standardized mortality rates can be observed starting from 2018 (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>, <xref ref-type="fig" rid="f3"><bold>Figure 3</bold></xref>).</p>
<p>This trend of increasing mortality has also been observed in other EU member states. Namely, between 1990 and 2017, all EU15+ countries have had an increase in mortality in women, and an increase in mortality in men was observed in as many as 16 out of 19 of the countries. A negative trend was reported in Italy (-25.1%), Portugal (-1.9%), and Sweden (-0.6%). (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>, <xref ref-type="bibr" rid="r23"><italic>23</italic></xref>) The etiology of the mortality increase is multifactorial, and can certainly be largely ascribed to the dynamics of the disease in the population. Improved registration of causes of death may have also contributed to the positive trend, since inadequate identification of this disease in the general population and reduced awareness represents a global problem. Studies in other countries have indicated inadequate knowledge on PAD in both the general population and in medical professionals, but no such studies have been conducted in the Republic of Croatia. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r24"><italic>24</italic></xref>)</p>
<p>The results of our study indicate a wide spectrum of mortality rates by sex and by region. For 2020, the ratio of the highest and lowest mortality rate in the City of Zagreb in comparison with the Adriatic region indicates a 40% higher mortality in men and a 70% higher rate in women. Northern Croatia has the highest average mortality rate for both sexes. Men, except in the City of Zagreb, have higher average mortality rates in all the other regions (<xref ref-type="table" rid="t2"><bold>Table 2</bold></xref>). Mortality was significantly higher in men in Pannonian and Adriatic Croatia in comparison with the City of Zagreb and Northern Croatia, where men and women had similar rates (<xref ref-type="fig" rid="f4"><bold>Figure 4</bold></xref>).</p>
<p>Sex is a significant factor in diagnosis and therapy selection. (<xref ref-type="bibr" rid="r25"><italic>25</italic></xref>) In women, the clinical symptoms of PAD are often not present, resulting in failure to diagnose and treat the disease according to recommendations. (<xref ref-type="bibr" rid="r26"><italic>26</italic></xref>) These systemic errors can influence study outcomes and must be considered when interpreting epidemiological indicators. Furthermore, significant regional differences in mortality were observed within the same sex. For example, men in Northern Croatia had significantly higher mortality than men in Adriatic Croatia, whereas mortality rates were similar among other regions. These results are to be expected due to lower prevalence of risk factors and the protective cardiovascular effect of the Mediterranean lifestyle in Adriatic Croatia. Mortality rates in women were similar in the City of Zagreb and in Northern Croatia, but the City of Zagreb had significantly higher mortality rates in comparison with Adriatic and Pannonian Croatia. When examining other regions, we can conclude that Northern Croatia has significantly higher mortality rates than Adriatic and Pannonian Croatia, and the Pannonian region has higher rates than Adriatic Croatia (<xref ref-type="fig" rid="f4"><bold>Figure 4</bold></xref>). These differences can be primarily ascribed to risk factors and the lack of effective prevention, although the influence of better identification of the disease itself cannot be excluded. Namely, the national program for the prevention of CVD from 2001 was not applied in clinical practice, and it was also subsequently determined that there were clinical and public health practices that did not match recommendations applied in other countries. Some regions, such as Adriatic Croatia, have implemented preventive programs for CVD that may have reduced morbidity and mortality. (<xref ref-type="bibr" rid="r27"><italic>27</italic></xref>) It should be emphasized that the Croatian healthcare systems lacks strategies for the prevention of leading causes of poor health such as smoking, high arterial pressure, and poor diet, which would be implemented at all levels of healthcare. (<xref ref-type="bibr" rid="r28"><italic>28</italic></xref>)</p>
<p>Furthermore, no national studies have been conducted that would quantify the effect of risk factors on morbidity, mortality, and treatment costs for CVD, and aggregated data used in the present study limits the precise determination of the possible causes of differences in mortality. However, all epidemiological studies emphasize the very large role played by prevention, estimating that reducing risk factors would prevent as much as 80% of cardiovascular diseases. When examining mortality form CVD alone, it can be said that more than half is ascribable to risk factors, with the rest being determined by medical care. (<xref ref-type="bibr" rid="r29"><italic>29</italic></xref>-<xref ref-type="bibr" rid="r31"><italic>31</italic></xref>) Education and awareness of the general population and of medical professionals is a precondition for reducing the high prevalence of traditional risk factors. Education is lacking in Croatia, both among medical students and in the general population, since only a third of the population is aware that CVDs are the leading cause of death. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r6"><italic>6</italic></xref>, <xref ref-type="bibr" rid="r32"><italic>32</italic></xref>, <xref ref-type="bibr" rid="r33"><italic>33</italic></xref>) Although no studies have been conducted in the general population on knowledge of the etiology of PAD, we may assume that, as in other populations, knowledge on this disease is worse in comparison with other CVDs, such as IHD. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>, <xref ref-type="bibr" rid="r34"><italic>34</italic></xref>) Even clinicians are often unaware that mortality from PAD surpasses mortality from coronary heart disease. (<xref ref-type="bibr" rid="r35"><italic>35</italic></xref>)</p>
<p>The Republic of Croatia is an EU member state that is severely burdened by CV risk factors. Along with hypertension, environmental risk factors, smoking, and risks associated with diet are the strongest contributors to mortality and morbidity. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>) Smoking and diabetes are especially important in the etiology of PAD. The prevalence of smoking in 2019 was 32.6% in women and 39.1% in men. From 1990 to 2019, the prevalence of smoking was reduced both in women and in men, by -11.7% and -17.6%, respectively, but the negative trend has been significantly worse in comparison with Central European countries. In the same period, Poland reduced smoking by -17.8% in women and by as much as -40.5% in men. (<xref ref-type="bibr" rid="r36"><italic>36</italic></xref>) Despite the limitations imposed by regional comparisons, the poor success of reduction in the prevalence of smoking in the Republic of Croatia is undoubtably attributable to the lack and inadequate application of demonstrably effective methods such as increasing the prices of tobacco products, advertising smoking cessation in information-providing media, introducing educational materials about hazardous effect of smoking into schools, reducing the capacity of the tobacco industry to market its products, and introducing social norms that make smoking an unacceptable behavior. (<xref ref-type="bibr" rid="r37"><italic>37</italic></xref>) Aside from smoking, the Republic of Croatia is the EU member state with the highest ratio of women and men with unregulated hypertension, 38% and 36%, respectively. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>, <xref ref-type="bibr" rid="r38"><italic>38</italic></xref>) The burden of hypertension is unequally distributed by region, with a higher burden in continental regions and in persons with lower socioeconomic status. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>, <xref ref-type="bibr" rid="r39"><italic>39</italic></xref>) In addition to the extremely high prevalence of diagnosed hypertension, it is estimated that as many as one sixth of patients have undiagnosed hypertension, which firmly identifies this disease as an urgent public health issue. Regional differences are present as well, with the ratio of patients with undiagnosed hypertension being higher in Adriatic Croatia. (<xref ref-type="bibr" rid="r40"><italic>40</italic></xref>) In Europe, patients with PAD usually have a combination of multiple risk factors that include hypertension, dyslipidemia, and increased waist circumference. (<xref ref-type="bibr" rid="r41"><italic>41</italic></xref>)</p>
<p>Risks associated with diet are, along with smoking, the most common causes of mortality and morbidity. (<xref ref-type="bibr" rid="r42"><italic>42</italic></xref>) The dietary patterns of the Croatian population increasingly resemble Western diet due to the loss of Mediterranean heritage in transitional processes. The term &#x201C;the Croatian paradox&#x201D; was coined to emphasize the discrepancy between having CVD mortality rates similar to those in countries of Eastern and Central Europe despite belonging to the group of Mediterranean countries. (<xref ref-type="bibr" rid="r43"><italic>43</italic></xref>, <xref ref-type="bibr" rid="r44"><italic>44</italic></xref>) In addition to unhealthy diet, it is important to emphasize the role of physical inactivity, which is associated with obesity and increased waist circumference. The prevalence of physical inactivity differs by sex, age, and region. A trend change was observed two decades ago, and almost 36% of the population was physically inactive at the start of the 2000s. Regional differences were also pronounced at the time, with 85.6% of men being physically inactive in the City of Zagreb, as opposed to 15% in Southern Croatia. The distribution by age was unfavorable, and prevalence was highest in the 18-34 age group, which is the period in life where exercise and physical activity habits are predominantly acquired, whereas prevalence was lowest in middle age in both sexes. (<xref ref-type="bibr" rid="r45"><italic>45</italic></xref>) One decade later, 80% of the adult population was physically active, more so men than women, which represented a positive change. However, the ratio of adolescents who achieved the recommended level of physical activity according the World Health Organization remained low at 25%. (<xref ref-type="bibr" rid="r46"><italic>46</italic></xref>) Despite the recommendations for physical activity, sedentary behavior, and sleep from 2019, this ratio in adolescents remained the same in 2021, when it was also determined that only the healthcare and social welfare systems follow and monitor the level of physical activity in the population. (<xref ref-type="bibr" rid="r47"><italic>47</italic></xref>, <xref ref-type="bibr" rid="r48"><italic>48</italic></xref>) The evidence on the benefits of physical activity for the reduction of the incidence of numerous chronic non-infectious diseases, including CVDs, is beyond doubt. (<xref ref-type="bibr" rid="r49"><italic>49</italic></xref>) The present study highlights the noticeable correlation between the level of physical inactivity and the mortality rate due to PAD in Continental Croatia and the City of Zagreb in comparison with Adriatic Croatia, although methodological differences limit the assessment of the causal relationship between the two. Cohort studies would allow precise quantification of the protective role of physical activity for PAD-related morbidity and mortality.</p>
<p>In addition to the dominant role of risk factors in morbidity and mortality, it is also important not to neglect the comparably important influence of medical interventions in more clinically severe forms of PAD. In comparison with the neighboring Hungary, which has the highest amputation rate in Europe, as well as in comparison with Germany and Austria, the Republic of Croatia has noticeably lower age-standardized mortality rates due to PAD, which were similar to the European average for both sexes in the period from 1990 to 2019. (<xref ref-type="bibr" rid="r50"><italic>50</italic></xref>) However, systematic analyses cannot be performed due to the lack of informational interconnectedness between all levels of healthcare, which prevents routine quantification of the number of interventions per medical institution and monitoring treatment outcomes, cost-benefit analyses, and cost-efficiency analyses. (<xref ref-type="bibr" rid="r51"><italic>51</italic></xref>, <xref ref-type="bibr" rid="r52"><italic>52</italic></xref>) The observed regional differences in mortality are certainly also partially ascribable to the differences in the distribution of human and technological potential in the specialist branches that provide care for patients with PAD, such as radiology, cardiology, and vascular surgery. Previous studies indicate the existence of regional differences in the availability of medical services, such as differences in waiting times for diagnostic examination using computed tomography (CT) and magnetic resonance (MR) imaging, but also differences in mortality from acute and recurrent myocardial infarction. (<xref ref-type="bibr" rid="r53"><italic>53</italic></xref>-<xref ref-type="bibr" rid="r56"><italic>56</italic></xref>) Additionally, the mortality from PAD, as with acute coronary syndrome, is ascribable to the natural course of the disease, but can also be caused by medical, endovascular, or surgical interventions, which necessitates differentiating and recording spontaneous unwanted outcomes as opposed to unwanted outcomes associated with medical interventions. (<xref ref-type="bibr" rid="r57"><italic>57</italic></xref>, <xref ref-type="bibr" rid="r58"><italic>58</italic></xref>)</p>
<p>The present study had certain advantages and disadvantages, the latter being the study limitations and the possibility of systemic errors. Its greatest advantage is the fact that this was the first study to quantify the regional differences in PAD-related mortality. According to the WHO, mortality statistics are one of the most reliable sources of scientific data. Mortality data are used for assessing the overall state of health in the population, creating health-related policies, evaluating national healthcare programs, and performing regional and international comparisons. The authors of the Global Burden of Disease (GBD) project analyzed the quality of mortality data in EU member states and evaluated the reliability of annual assessments of causes of death on a scale ranging from 1 to 5, with Croatia being among 14 other countries (Belgium, Bulgaria, the Czech Republic, Denmark, France, Germany, Greece, Luxemburg, the Netherlands, Poland, Portugal, Romania, Slovenia, and Spain) that were marked with a score of 4, indicating that the completeness of mortality data was higher than 65%. (<xref ref-type="bibr" rid="r59"><italic>59</italic></xref>)</p>
<p>Along with these advantages, the present study had numerous limitations that should be considered when interpreting the data. Firstly, from a methodological perspective, this was an observational study, which means that it can provide only limited demonstration of causal relationships. Furthermore, it is likely that PAD is less often diagnosed as a cause of death than for instance IHD, despite both diseases having atherosclerotic processes as the underlying cause. The causes of death in PAD are rarely the direct result of the disease of the lower extremities, and it is estimated that every other patient with this disease dies from complications related to coronary disease, and every tenth patient dies from complications related to cerebrovascular disease. (<xref ref-type="bibr" rid="r60"><italic>60</italic></xref>) The comparability of this study is limited, as there is no unified application of ICD diagnoses among different countries. However, despite the lack of comparability at the international level, comparisons between regions are possible, since the existence of systemic errors at the regional level that would lead to differences in outcomes is not anticipated. It is possible that the larger number of medical centers performing treatment on patients with PAD in the City of Zagreb has resulted in improved coding of mortality causes, but there are no studies quantifying such discrepancies between centers. Peripheral artery disease can certainly be included in the group of diseases in which the ICD system does not fully represent the complexity of the clinical picture. (<xref ref-type="bibr" rid="r61"><italic>61</italic></xref>) Given the clinical course of the disease, it is likely that the more severe forms of the disease are diagnosed, while the majority of the cases remains asymptomatic and are thus diagnosed less often. (<xref ref-type="bibr" rid="r62"><italic>62</italic></xref>)</p>
<p>In conclusion, despite aggregated data and its limitations, this study has shown significant regional differences in mortality due to PAD, with an increasing trend since 2018. Northern Croatia had the highest mortality for both sexes, while Adriatic Croatia had the lowest mortality. Estimating causal relationships is difficult due to the ecological study design, which was the result of the lack of systematic data collection that includes treatment outcomes. However, epidemiological studies emphasize the role of prevention and early diagnostic in the reduction of mortality, and the effectiveness of this approach is undoubtably also applicable to patients with PAD.</p>
</sec>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeper</surname><given-names>NJ</given-names></name><name><surname>Hamburg</surname><given-names>NM</given-names></name></person-group>. <article-title>Peripheral Vascular Disease in 2021.</article-title> <source>Circ Res</source>. <year>2021</year> June 11;<volume>128</volume>(<issue>12</issue>):<fpage>1803</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.319562</pub-id><pub-id pub-id-type="pmid">34110903</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallino</surname><given-names>A</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Diehm</surname><given-names>C</given-names></name><name><surname>Cosentino</surname><given-names>F</given-names></name><name><surname>Stricker</surname><given-names>H</given-names></name><name><surname>Falk</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Non-coronary atherosclerosis.</article-title> <source>Eur Heart J</source>. <year>2014</year> March 3;<volume>35</volume>(<issue>17</issue>):<fpage>1112</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehu071</pub-id><pub-id pub-id-type="pmid">24595865</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowkes</surname><given-names>FGR</given-names></name><name><surname>Rudan</surname><given-names>D</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Denenberg</surname><given-names>JO</given-names></name><name><surname>McDermott</surname><given-names>MM</given-names></name><etal/></person-group> <article-title>Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.</article-title> <source>Lancet</source>. <year>2013</year> October;<volume>382</volume>(<issue>9901</issue>):<fpage>1329</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61249-0</pub-id><pub-id pub-id-type="pmid">23915883</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argyriou</surname><given-names>C</given-names></name><name><surname>Saleptsis</surname><given-names>V</given-names></name><name><surname>Koutsias</surname><given-names>S</given-names></name><name><surname>Giannoukas</surname><given-names>AD</given-names></name></person-group>. <article-title>Peripheral arterial disease is prevalent but underdiagnosed and undertreated in the primary care setting in Central Greece.</article-title> <source>Angiology</source>. <year>2013</year> March 16;<volume>64</volume>(<issue>2</issue>):<fpage>119</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1177/0003319712439092</pub-id><pub-id pub-id-type="pmid">22427490</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>&#x017D;</given-names></name><name><surname>De Sutter</surname><given-names>J</given-names></name><name><surname>Ryd&#x00E9;n</surname><given-names>L</given-names></name><name><surname>Mirrakhimov</surname><given-names>EM</given-names></name><name><surname>Pogosova</surname><given-names>N</given-names></name><name><surname>Dolzhenko</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Peripheral arterial disease and intermittent claudication in coronary heart disease patients.</article-title> <source>Int J Cardiol</source>. <year>2021</year> January 1;<volume>322</volume>:<fpage>227</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2020.09.004</pub-id><pub-id pub-id-type="pmid">32918939</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name></person-group>. <article-title>Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019.</article-title> <source>Front Cardiovasc Med</source>. <year>2022</year> April 12;<volume>9</volume>: <pub-id pub-id-type="doi">10.3389/fcvm.2022.868370</pub-id><pub-id pub-id-type="pmid">35498034</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="other">Bergman-Markovi&#x0107; B. Procjena ukupnog kardiovaskularnog rizika. Zagreb: Dru&#x0161;tvo nastavnika op&#x0107;e/obiteljske medicine; 2013.</mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="other">Organisation for Economic Co-operation and Development (OECD). Croatia: Country Health Profile 2019. State of Health in the EU [Internet]. Paris: OECD Publishing; Brussels: European Observatory on Health Systems and Policies. 2019 [cited 2023 May 22]. Available from: <pub-id pub-id-type="doi">10.1787/b63e8c9f-en</pub-id><pub-id pub-id-type="doi">10.1787/b63e8c9f-en</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="other">Kati&#x0107; M, Jure&#x0161;a V, Bergman-Markovi&#x0107; B. Preventivni program kardiovaskularnih bolesti u obiteljskoj medicini. Zagreb: Ministarstvo zdravstva Republike Hrvatske; Sveu&#x010D;ili&#x0161;te u Zagrebu, Medicinski fakultet, &#x0160;kola narodnog zdravlja &#x201E;Andrija &#x0160;tampar&#x201C;; 2003.</mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osvaldi&#x0107;</surname><given-names>J</given-names></name></person-group>. <article-title>Information system implementation in healthcare: case study of Croatia.</article-title> <source>Bus Syst Res J.</source> <year>2021</year> December 1;<volume>12</volume>(<issue>2</issue>):<fpage>114</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.2478/bsrj-2021-0022</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birmpili</surname><given-names>P</given-names></name><name><surname>Atkins</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Johal</surname><given-names>AS</given-names></name><name><surname>Waton</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Evaluation of the ICD-10 system in coding revascularisation procedures in patients with peripheral arterial disease in England: a retrospective cohort study using national administrative and clinical databases.</article-title> <source>EClinicalMedicine</source>. <year>2022</year> January;<volume>55</volume>:<elocation-id>101738</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2022.101738</pub-id><pub-id pub-id-type="pmid">36386037</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rammos</surname><given-names>C</given-names></name><name><surname>Steinmetz</surname><given-names>M</given-names></name><name><surname>Lortz</surname><given-names>J</given-names></name><name><surname>Mahabadi</surname><given-names>AA</given-names></name><name><surname>Petrikhovich</surname><given-names>O</given-names></name><name><surname>Kirsch</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Peripheral artery disease in Germany (2009&#x2013;2018): prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy &#x2013; a population-based study.</article-title> <source>Lancet Reg Health Eur</source>. <year>2021</year> May 3;<volume>5</volume>:<elocation-id>100113</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100113</pub-id><pub-id pub-id-type="pmid">34557822</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="web">Peripheral artery disease (PAD): provider&#x2019;s guide to diagnose and code PAD [Internet]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cigna.com/static/docs/starplus/icd10-peripheral-artery-disease.pdf">https://www.cigna.com/static/docs/starplus/icd10-peripheral-artery-disease.pdf</ext-link></mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Halperin</surname><given-names>JL</given-names></name><name><surname>Albert</surname><given-names>NM</given-names></name><name><surname>Bozkurt</surname><given-names>B</given-names></name><name><surname>Brindis</surname><given-names>RG</given-names></name><name><surname>Curtis</surname><given-names>LH</given-names></name><etal/></person-group> <article-title>Management of patients with peripheral artery disease (Compilation of 2005 and 2011 ACCF/AHA guideline recommendations).</article-title> <source>Circulation</source>. <year>2013</year> April 2;<volume>127</volume>(<issue>13</issue>):<fpage>1425</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0b013e31828b82aa</pub-id><pub-id pub-id-type="pmid">23457117</pub-id></mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="web">Hrvatski zavod za javno zdravstvo (HZJZ). Izvje&#x0161;&#x0107;e o umrlim osobama u Hrvatskoj u 2021. godini [Internet]. Zagreb; HZJZ; 2022 [cited 2023 Sep 10]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.hzjz.hr/periodicne-publikacije/izvjesce-o-umrlim-osobama-u-hrvatskoj-u-2021-godini/">https://www.hzjz.hr/periodicne-publikacije/izvjesce-o-umrlim-osobama-u-hrvatskoj-u-2021-godini/</ext-link></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="web">Dr&#x017E;avni zavod za statistiku. Nacionalna klasifikacija statisti&#x010D;kih regija 2021. (HR_NUTS 2021.) [Internet]. Zagreb: Narodne novine; 2019 [cited 2023 Sep 15]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://narodne-novine.nn.hr/clanci/sluzbeni/full/2019_12_125_2507.html">https://narodne-novine.nn.hr/clanci/sluzbeni/full/2019_12_125_2507.html</ext-link></mixed-citation></ref>
<ref id="r17"><label>17</label><mixed-citation publication-type="web">Dr&#x017E;avni zavod za statistiku. PX-Axis baze podataka [Internet]. Zagreb: Dr&#x017E;avni zavod za statistiku; c2023. [cited 2023 Sep 15]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.dzs.hr/PXWeb/Menu.aspx?px_db=Stanovni">https://web.dzs.hr/PXWeb/Menu.aspx?px_db=Stanovni</ext-link>%u0161tvo&amp;px_language=hr</mixed-citation></ref>
<ref id="r18"><label>18</label><mixed-citation publication-type="web">Eurostat; Pace M, Gissler M, Lanzieri G, Grande E, Wojtyniak B, et al. Revision of the European Standard Population: report of Eurostat&#x2019;s task force.&#x202F;2013 ed. [Internet]. Luxembourg: Publications Office of the European Union; 2013 [cited 2023 Sep 15]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://data.europa.eu/doi/10.2785/11470">https://data.europa.eu/doi/10.2785/11470</ext-link></mixed-citation></ref>
<ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crocetti</surname><given-names>E</given-names></name><name><surname>Dyba</surname><given-names>T</given-names></name><name><surname>Martos</surname><given-names>C</given-names></name><name><surname>Randi</surname><given-names>G</given-names></name><name><surname>Rooney</surname><given-names>R</given-names></name><name><surname>Bettio</surname><given-names>M</given-names></name></person-group>. <article-title>The need for a rapid and comprehensive adoption of the revised European standard population in cancer incidence comparisons.</article-title> <source>Eur J Cancer Prev</source>. <year>2017</year> September 1;<volume>26</volume>(<issue>5</issue>):<fpage>447</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/CEJ.0000000000000250</pub-id><pub-id pub-id-type="pmid">26919133</pub-id></mixed-citation></ref>
<ref id="r20"><label>20</label><mixed-citation publication-type="web">JASP Team. JASP. Version 0.17.2 [software]. 2023 May 30 [cited 2023 Sep 10]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://jasp-stats.org/download/">https://jasp-stats.org/download/</ext-link></mixed-citation></ref>
<ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Lehto</surname><given-names>S</given-names></name><name><surname>R&#x00F6;nnemaa</surname><given-names>T</given-names></name><name><surname>Py&#x00F6;r&#x00E4;l&#x00E4;</surname><given-names>K</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name></person-group>. <article-title>Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.</article-title> <source>N Engl J Med</source>. <year>1998</year>;<volume>339</volume>(<issue>4</issue>):<fpage>229</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199807233390404</pub-id><pub-id pub-id-type="pmid">9673301</pub-id></mixed-citation></ref>
<ref id="r22"><label>22</label><mixed-citation publication-type="web">Hrvatski zavod za javno zdravstvo (HZJZ). Dijabetes [Internet]. Zagreb: HZJZ; c2023 [cited 2023 Sep 15]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.hzjz.hr/sluzba-epidemiologija-prevencija-nezaraznih-bolesti/odjel-za-koordinaciju-i-provodenje-programa-i-projekata-za-prevenciju-kronicnih-nezaraznih-bolest/dijabetes">https://www.hzjz.hr/sluzba-epidemiologija-prevencija-nezaraznih-bolesti/odjel-za-koordinaciju-i-provodenje-programa-i-projekata-za-prevenciju-kronicnih-nezaraznih-bolest/dijabetes</ext-link></mixed-citation></ref>
<ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodall</surname><given-names>R</given-names></name><name><surname>Salciccioli</surname><given-names>JD</given-names></name><name><surname>Davies</surname><given-names>AH</given-names></name><name><surname>Marshall</surname><given-names>D</given-names></name><name><surname>Shalhoub</surname><given-names>J</given-names></name></person-group>. <article-title>Trends in peripheral arterial disease incidence and mortality in EU15+ countries 1990&#x2013;2017.</article-title> <source>Eur J Prev Cardiol</source>. <year>2021</year> September 20;<volume>28</volume>(<issue>11</issue>):<fpage>1201</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1177/2047487319899626</pub-id><pub-id pub-id-type="pmid">34551087</pub-id></mixed-citation></ref>
<ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>AT</given-names></name></person-group>. <article-title>Peripheral arterial disease detection, awareness, and treatment in Primary Care.</article-title> <source>JAMA</source>. <year>2001</year> September 19;<volume>286</volume>(<issue>11</issue>):<fpage>1317</fpage>. <pub-id pub-id-type="doi">10.1001/jama.286.11.1317</pub-id><pub-id pub-id-type="pmid">11560536</pub-id></mixed-citation></ref>
<ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>MM</given-names></name><name><surname>Pai</surname><given-names>JK</given-names></name><name><surname>Bertoia</surname><given-names>ML</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Mittleman</surname><given-names>MA</given-names></name><etal/></person-group> <article-title>Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.</article-title> <source>JAMA</source>. <year>2012</year> October 24;<volume>308</volume>(<issue>16</issue>):<fpage>1660</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2012.13415</pub-id><pub-id pub-id-type="pmid">23093164</pub-id></mixed-citation></ref>
<ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teodorescu</surname><given-names>VJ</given-names></name><name><surname>Vavra</surname><given-names>AK</given-names></name><name><surname>Kibbe</surname><given-names>MR</given-names></name></person-group>. <article-title>Peripheral arterial disease in women.</article-title> <source>J Vasc Surg</source>. <year>2013</year> April;<volume>57</volume>(<issue>4</issue>) <supplement>Suppl</supplement>:<fpage>18S</fpage>&#x2013;<lpage>26S</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2012.10.115</pub-id><pub-id pub-id-type="pmid">23522713</pub-id></mixed-citation></ref>
<ref id="r27"><label>27</label><mixed-citation publication-type="web">Kata&#x010D;i&#x0107; J, Grozi&#x0107;-&#x017D;ivoli&#x0107; S. Jadranska mre&#x017E;a prevencije kardiovaskularnih bolesti: Love Your Heart. Epoha zdravlja. 2015;8(1):26. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hrcak.srce.hr/file/222735">https://hrcak.srce.hr/file/222735</ext-link></mixed-citation></ref>
<ref id="r28"><label>28</label><mixed-citation publication-type="other">Organisation for Economic Co-operation and Development (OECD). Croatia: Country Health Profile 2017. State of Health in the EU [Internet]. Paris: OECD Publishing; Brussels: European Observatory on Health Systems and Policies. 2017 [cited 2023 May 22]. Available from: <pub-id pub-id-type="doi">10.1787/9789264283312-en</pub-id><pub-id pub-id-type="doi">10.1787/9789264283312-en</pub-id></mixed-citation></ref>
<ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piepoli</surname><given-names>MF</given-names></name><name><surname>Hoes</surname><given-names>AW</given-names></name><name><surname>Agewall</surname><given-names>S</given-names></name><name><surname>Albus</surname><given-names>C</given-names></name><name><surname>Brotons</surname><given-names>C</given-names></name><name><surname>Catapano</surname><given-names>AL</given-names></name><etal/></person-group> <article-title>2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR).</article-title> <source>Eur Heart J</source>. <year>2016</year>;<volume>37</volume>(<issue>29</issue>):<fpage>2315</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehw106</pub-id><pub-id pub-id-type="pmid">27222591</pub-id></mixed-citation></ref>
<ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>F</given-names></name><name><surname>Chatenoud</surname><given-names>L</given-names></name><name><surname>Bertuccio</surname><given-names>P</given-names></name><name><surname>Lucchini</surname><given-names>F</given-names></name><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group>. <article-title>Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update.</article-title> <source>Eur J Cardiovasc Prev Rehabil</source>. <year>2009</year> June 1;<volume>16</volume>(<issue>3</issue>):<fpage>333</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1097/HJR.0b013e328325d67d</pub-id><pub-id pub-id-type="pmid">19369880</pub-id></mixed-citation></ref>
<ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>ES</given-names></name><name><surname>Capewell</surname><given-names>S</given-names></name></person-group>. <article-title>Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002.</article-title> <source>J Am Coll Cardiol</source>. <year>2007</year> November;<volume>50</volume>(<issue>22</issue>):<fpage>2128</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2007.05.056</pub-id><pub-id pub-id-type="pmid">18036449</pub-id></mixed-citation></ref>
<ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>Z</given-names></name><name><surname>Sonicki</surname><given-names>Z</given-names></name><name><surname>Tedeschi-Reiner</surname><given-names>E</given-names></name></person-group>. <article-title>Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey.</article-title> <source>Prev Med</source>. <year>2010</year> December;<volume>51</volume>(<issue>6</issue>):<fpage>494</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2010.09.015</pub-id><pub-id pub-id-type="pmid">20951724</pub-id></mixed-citation></ref>
<ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>&#x017D;</given-names></name><name><surname>Sonicki</surname><given-names>Z</given-names></name><name><surname>Tedeschi-Reiner</surname><given-names>E</given-names></name></person-group>. <article-title>The perception and knowledge of cardiovascular risk factors among medical students.</article-title> <source>Croat Med J</source>. <year>2012</year> June;<volume>53</volume>(<issue>3</issue>):<fpage>278</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.3325/cmj.2012.53.278</pub-id><pub-id pub-id-type="pmid">22661142</pub-id></mixed-citation></ref>
<ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaff</surname><given-names>MR</given-names></name></person-group>. <article-title>Why patients know more about cars than peripheral artery disease.</article-title> <source>Circulation</source>. <year>2014</year> November 11;<volume>130</volume>(<issue>20</issue>):<fpage>1778</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.012872</pub-id><pub-id pub-id-type="pmid">25239437</pub-id></mixed-citation></ref>
<ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agnelli</surname><given-names>G</given-names></name><name><surname>Belch</surname><given-names>JJF</given-names></name><name><surname>Baumgartner</surname><given-names>I</given-names></name><name><surname>Giovas</surname><given-names>P</given-names></name><name><surname>Hoffmann</surname><given-names>U</given-names></name></person-group>. <article-title>Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review.</article-title> <source>Atherosclerosis</source>. <year>2020</year> January;<volume>293</volume>:<fpage>94</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2019.09.012</pub-id><pub-id pub-id-type="pmid">31606132</pub-id></mixed-citation></ref>
<ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reitsma</surname><given-names>MB</given-names></name><name><surname>Kendrick</surname><given-names>PJ</given-names></name><name><surname>Ababneh</surname><given-names>E</given-names></name><name><surname>Abbafati</surname><given-names>C</given-names></name><name><surname>Abbasi-Kangevari</surname><given-names>M</given-names></name><name><surname>Abdoli</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990&#x2013;2019: a systematic analysis from the Global Burden of Disease Study 2019.</article-title> <source>Lancet</source>. <year>2021</year> June 19;<volume>397</volume>(<issue>10292</issue>):<fpage>2337</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(21)01169-7</pub-id><pub-id pub-id-type="pmid">34051883</pub-id></mixed-citation></ref>
<ref id="r37"><label>37</label><mixed-citation publication-type="web">National Institute on Drug Abuse. How can we prevent tobacco use? [Internet]. North Bethesda, MD: National Institute on Drug Abuse; 2022 [cited 2023 May 22]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/how-can-we-prevent-tobacco-use">https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/how-can-we-prevent-tobacco-use</ext-link></mixed-citation></ref>
<ref id="r38"><label>38</label><mixed-citation publication-type="web">Eurostat. 22% of people in the EU have high blood pressure [Internet]. Luxembourg: Eurostat; 2021 [cited 2023 May 22]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210929-1">https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210929-1</ext-link></mixed-citation></ref>
<ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markovi&#x0107;</surname><given-names>BB</given-names></name><name><surname>Kranjcevi&#x0107;</surname><given-names>K</given-names></name><name><surname>Reiner</surname><given-names>Z</given-names></name><name><surname>Blazekovi&#x0107;</surname><given-names>SM</given-names></name><name><surname>Spehar</surname><given-names>SS</given-names></name></person-group>. <article-title>Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.</article-title> <source>Croat Med J</source>. <year>2005</year> December 1;<volume>46</volume>(<issue>6</issue>):<fpage>984</fpage>&#x2013;<lpage>9</lpage>. Available from <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16342354/">https://pubmed.ncbi.nlm.nih.gov/16342354/</ext-link><pub-id pub-id-type="pmid">16342354</pub-id></mixed-citation></ref>
<ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivi&#x010D;evi&#x0107; Uhernik</surname><given-names>A</given-names></name><name><surname>Kralj</surname><given-names>V</given-names></name><name><surname>&#x010C;ukelj</surname><given-names>P</given-names></name><name><surname>Brki&#x0107;-Bilo&#x0161;</surname><given-names>I</given-names></name><name><surname>Erceg</surname><given-names>M</given-names></name><name><surname>Benjak</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Undiagnosed hypertension in Croatia.</article-title> <source>Croat Med J</source>. <year>2023</year> February 28;<volume>64</volume>(<issue>1</issue>):<fpage>4</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3325/cmj.2023.64.4</pub-id><pub-id pub-id-type="pmid">36864813</pub-id></mixed-citation></ref>
<ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olinic</surname><given-names>DM</given-names></name><name><surname>Spinu</surname><given-names>M</given-names></name><name><surname>Olinic</surname><given-names>M</given-names></name><name><surname>Homorodean</surname><given-names>C</given-names></name><name><surname>Tataru</surname><given-names>DA</given-names></name><name><surname>Liew</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Epidemiology of peripheral artery disease in Europe: VAS Educational Paper.</article-title> <source>Int Angiol</source>. <year>2018</year> August;<volume>37</volume>(<issue>4</issue>):<fpage>327</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.23736/S0392-9590.18.03996-2</pub-id><pub-id pub-id-type="pmid">29936722</pub-id></mixed-citation></ref>
<ref id="r42"><label>42</label><mixed-citation publication-type="web">Institute for Health Metrics and Evaluation (IHME). Croatia [Internet]. Seattle, WA: IHME; 2015 [cited 2023 May 22]. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.healthdata.org/croatia">https://www.healthdata.org/croatia</ext-link></mixed-citation></ref>
<ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x00FC;ller-Nordhorn</surname><given-names>J</given-names></name><name><surname>Binting</surname><given-names>S</given-names></name><name><surname>Roll</surname><given-names>S</given-names></name><name><surname>Willich</surname><given-names>SN</given-names></name></person-group>. <article-title>An update on regional variation in cardiovascular mortality within Europe.</article-title> <source>Eur Heart J</source>. <year>2008</year>;<volume>29</volume>:<fpage>1316</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehm604</pub-id><pub-id pub-id-type="pmid">18256043</pub-id></mixed-citation></ref>
<ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>&#x017D;</given-names></name><name><surname>Tedeschi-Reiner</surname><given-names>E</given-names></name></person-group>. <article-title>Atherosclerosis &#x2014; a paradox of Eastern European countries.</article-title> <source>Atheroscler Suppl</source>. <year>2006</year> January;<volume>7</volume>(<issue>3</issue>):<fpage>461</fpage>. <pub-id pub-id-type="doi">10.1016/S1567-5688(06)81854-4</pub-id></mixed-citation></ref>
<ref id="r45"><label>45</label><mixed-citation publication-type="web">Misigoj-Durakovi&#x0107; M, Heimer S, Gredelj M, Zeljko H, Sori&#x0107; M. Tjelesna neaktivnost u Republici Hrvatskoj [Physical inactivity in Croatia]. Acta Med Croat. 2007 Jun;61(3):253-8. Croatian. PubMed: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17629099/">https://pubmed.ncbi.nlm.nih.gov/17629099/</ext-link></mixed-citation></ref>
<ref id="r46"><label>46</label><mixed-citation publication-type="web">World Health Organization. (2010). Croatia physical activity factsheet 2010. Retrieved December 28, 2020, from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ec.europa.eu/assets/eac/sport/library/factsheets/croatia-factsheet_en.pdf">https://ec.europa.eu/assets/eac/sport/library/factsheets/croatia-factsheet_en.pdf</ext-link></mixed-citation></ref>
<ref id="r47"><label>47</label><mixed-citation publication-type="web">Juraki&#x0107; D, Pedi&#x0161;i&#x0107; &#x017D;. Hrvatske 24-satne preporuke za tjelesnu aktivnost, sedentarno pona&#x0161;anje i spavanje: prijedlog utemeljen na sustavnom pregledu literature. Medicus [Internet]. 2019 [pristupljeno 28.12.2023.];28(2 Tjelesna aktivnost):143-153. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hrcak.srce.hr/227109">https://hrcak.srce.hr/227109</ext-link></mixed-citation></ref>
<ref id="r48"><label>48</label><mixed-citation publication-type="web">World Health Organization. (2010). Croatia physical activity factsheet 2010. Retrieved December 28 from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/spain/publications/m/item/physical-activity-factsheet-croatia-2021">https://www.who.int/spain/publications/m/item/physical-activity-factsheet-croatia-2021</ext-link></mixed-citation></ref>
<ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerner</surname><given-names>I</given-names></name><name><surname>Rakovac</surname><given-names>M</given-names></name><name><surname>Lazinica</surname><given-names>B</given-names></name></person-group>. <article-title>Leisure-time physical activity and absenteeism.</article-title> <source>Arh Hig Rada Toksikol</source>. <year>2017</year> September 26;<volume>68</volume>(<issue>3</issue>):<fpage>159</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1515/aiht-2017-68-2963</pub-id><pub-id pub-id-type="pmid">28976887</pub-id></mixed-citation></ref>
<ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horv&#x00E1;th</surname><given-names>L</given-names></name><name><surname>N&#x00E9;meth</surname><given-names>N</given-names></name><name><surname>Feh&#x00E9;r</surname><given-names>G</given-names></name><name><surname>K&#x00ED;v&#x00E9;s</surname><given-names>Z</given-names></name><name><surname>Endrei</surname><given-names>D</given-names></name><name><surname>Boncz</surname><given-names>I</given-names></name></person-group>. <article-title>Epidemiology of Peripheral Artery Disease: Narrative Review.</article-title> <source>Life (Basel)</source>. <year>2022</year> July 12;<volume>12</volume>(<issue>7</issue>):<fpage>1041</fpage>. <pub-id pub-id-type="doi">10.3390/life12071041</pub-id><pub-id pub-id-type="pmid">35888129</pub-id></mixed-citation></ref>
<ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x017E;akula</surname><given-names>A</given-names></name><name><surname>Vo&#x010D;anec</surname><given-names>D</given-names></name><name><surname>Banadinovi&#x0107;</surname><given-names>M</given-names></name><name><surname>Vajagi&#x0107;</surname><given-names>M</given-names></name><name><surname>Lon&#x010D;arek</surname><given-names>K</given-names></name><name><surname>Luka&#x010D;evi&#x0107; Lovren&#x010D;i&#x0107;</surname><given-names>I</given-names></name><etal/></person-group>, editors. <article-title>Croatia: health system review 2021</article-title> <comment>[Internet]</comment>. <source>Health Syst Transit</source>. <year>2021</year>;<volume>23</volume>(<issue>2</issue>):<fpage>1</fpage>&#x2013;<lpage>46</lpage>. [cited 2023 May 22] Available from <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://eurohealthobservatory.who.int/publications/i/croatia-health-system-review-2021">https://eurohealthobservatory.who.int/publications/i/croatia-health-system-review-2021</ext-link><pub-id pub-id-type="pmid">34994691</pub-id></mixed-citation></ref>
<ref id="r52"><label>52</label><mixed-citation publication-type="other">Organisation for Economic Co-operation and Development (OECD). Croatia: Country Health Profile 2021. State of Health in the EU [Internet]. Paris: OECD Publishing; Brussels: European Observatory on Health Systems and Policies. 2021 [cited 2023 May 22]. Available from: <pub-id pub-id-type="doi">10.1787/717e5510-en</pub-id><pub-id pub-id-type="doi">10.1787/717e5510-en</pub-id></mixed-citation></ref>
<ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biloglav</surname><given-names>Z</given-names></name><name><surname>Medakovi&#x0107;</surname><given-names>P</given-names></name><name><surname>Buljevi&#x0107;</surname><given-names>J</given-names></name><name><surname>&#x017D;uvela</surname><given-names>F</given-names></name><name><surname>Padjen</surname><given-names>I</given-names></name><name><surname>Vrki&#x0107;</surname><given-names>D</given-names></name><etal/></person-group> <article-title>The analysis of waiting time and utilization of computed tomography and magnetic resonance imaging in Croatia: a nationwide survey.</article-title> <source>Croat Med J</source>. <year>2020</year> December 1;<volume>61</volume>(<issue>6</issue>):<fpage>538</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.3325/cmj.2020.61.538</pub-id><pub-id pub-id-type="pmid">33410301</pub-id></mixed-citation></ref>
<ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biloglav</surname><given-names>Z</given-names></name><name><surname>Medakovi&#x0107;</surname><given-names>P</given-names></name><name><surname>Vrki&#x0107;</surname><given-names>D</given-names></name><name><surname>Brklja&#x010D;i&#x0107;</surname><given-names>B</given-names></name><name><surname>Padjen</surname><given-names>I</given-names></name><name><surname>&#x0106;uri&#x0107;</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Geographical and temporal distribution of radiologists, computed tomography and magnetic resonance scanners in Croatia.</article-title> <source>Inquiry</source>. <year>2021</year> January-December;<volume>58</volume>:<elocation-id>469580211060295</elocation-id>. <pub-id pub-id-type="doi">10.1177/00469580211060295</pub-id><pub-id pub-id-type="pmid">34807799</pub-id></mixed-citation></ref>
<ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biloglav</surname><given-names>Z</given-names></name><name><surname>Vidovi&#x0107;</surname><given-names>D</given-names></name><name><surname>Medakovi&#x0107;</surname><given-names>P</given-names></name><name><surname>Bulum</surname><given-names>J</given-names></name><name><surname>Brestovac</surname><given-names>M</given-names></name><name><surname>Glava&#x0161;</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Distribucija specijalista kardiologije po &#x017E;upanijama u Republici Hrvatskoj.</article-title> <source>Lijec Vjesn</source>. <year>2022</year>;<volume>144</volume>(<issue>7-8</issue>):<fpage>217</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.26800/LV-144-7-8-3</pub-id></mixed-citation></ref>
<ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biloglav</surname><given-names>Z</given-names></name><name><surname>Turudi&#x0107;</surname><given-names>M</given-names></name><name><surname>Vidovi&#x0107;</surname><given-names>D</given-names></name><name><surname>Medakovi&#x0107;</surname><given-names>P</given-names></name><name><surname>Glava&#x0161;</surname><given-names>B</given-names></name><name><surname>Padjen</surname><given-names>I</given-names></name><etal/></person-group> <article-title>Regionalne razlike u standardiziranim stopama mortaliteta od akutnog i ponovljenog infarkta miokarda u Republici Hrvatskoj od 2015. do 2019. godine.</article-title> <source>Lijec Vjesn</source>. <year>2023</year>;<volume>145</volume>(<issue>5-6</issue>):<fpage>191</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.26800/LV-145-5-6-3</pub-id></mixed-citation></ref>
<ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voci</surname><given-names>D</given-names></name><name><surname>Fedeli</surname><given-names>U</given-names></name><name><surname>Valerio</surname><given-names>L</given-names></name><name><surname>Schievano</surname><given-names>E</given-names></name><name><surname>Righini</surname><given-names>M</given-names></name><name><surname>Kucher</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Mortality rate related to peripheral arterial disease: a retrospective analysis of epidemiological data (years 2008&#x2013;2019).</article-title> <source>Nutr Metab Cardiovasc Dis</source>. <year>2023</year> March 1;<volume>33</volume>(<issue>3</issue>):<fpage>516</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2022.11.020</pub-id><pub-id pub-id-type="pmid">36642604</pub-id></mixed-citation></ref>
<ref id="r58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gherasie</surname><given-names>FA</given-names></name><name><surname>Popescu</surname><given-names>MR</given-names></name><name><surname>Bartos</surname><given-names>D</given-names></name></person-group>. <article-title>Acute coronary syndrome: disparities of pathophysiology and mortality with and without peripheral artery disease.</article-title> <source>J Pers Med</source>. <year>2023</year> June 2;<volume>13</volume>(<issue>6</issue>):<fpage>944</fpage>. <pub-id pub-id-type="doi">10.3390/jpm13060944</pub-id><pub-id pub-id-type="pmid">37373933</pub-id></mixed-citation></ref>
<ref id="r59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodall</surname><given-names>R</given-names></name><name><surname>Alazawi</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>W</given-names></name><name><surname>Bravis</surname><given-names>V</given-names></name><name><surname>Salciccioli</surname><given-names>JD</given-names></name><name><surname>Marshall</surname><given-names>DC</given-names></name><etal/></person-group> <article-title>Trends in type 2 diabetes mellitus disease burden in European Union countries between 1990 and 2019.</article-title> <source>Sci Rep</source>. <year>2021</year> July 28;<volume>11</volume>(<issue>1</issue>):<fpage>15356</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-94807-z</pub-id><pub-id pub-id-type="pmid">34321515</pub-id></mixed-citation></ref>
<ref id="r60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dormandy</surname><given-names>JA</given-names></name><name><surname>Rutherford</surname><given-names>RB</given-names></name></person-group>. <article-title>Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).</article-title> <source>J Vasc Surg</source>. <year>2000</year> January 1;<volume>31</volume>(<issue>1 Pt 2</issue>):<fpage>S1</fpage>&#x2013;<lpage>296</lpage>. Available from <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10666287/">https://pubmed.ncbi.nlm.nih.gov/10666287/</ext-link><pub-id pub-id-type="pmid">10666287</pub-id></mixed-citation></ref>
<ref id="r61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strnad</surname><given-names>M</given-names></name><name><surname>Mandic</surname><given-names>V</given-names></name><name><surname>Rulnjevic</surname><given-names>N</given-names></name></person-group>. <article-title>Croatian initial experience with the suitability of the ICIDH for classifying health status.</article-title> <source>Disabil Rehabil</source>. <year>1995</year> January 1;<volume>17</volume>(<issue>7</issue>):<fpage>364</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3109/09638289509166723</pub-id><pub-id pub-id-type="pmid">8680037</pub-id></mixed-citation></ref>
<ref id="r62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Sebastianski</surname><given-names>M</given-names></name><name><surname>Makowsky</surname><given-names>M</given-names></name><name><surname>Tsuyuki</surname><given-names>R</given-names></name><name><surname>McMurtry</surname><given-names>MS</given-names></name></person-group>. <article-title>Administrative data are not sensitive for the detection of peripheral artery disease in the community.</article-title> <source>Vasc Med</source>. <year>2016</year> August;<volume>21</volume>(<issue>4</issue>):<fpage>331</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1177/1358863X16631041</pub-id><pub-id pub-id-type="pmid">27114456</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
